Atypical and anaplastic meningiomas treated with bevacizumab

Journal of Neuro-Oncology, 05/03/2012

The findings suggest that bevacizumab was well–tolerated in the patients, and may be considered in patients who have exhausted radiation and surgical options.

Print Article Summary Cat 2 CME Report